1513.HK - Livzon Pharmaceutical Group Inc.
HKSE - HKSE Delayed Price. Currency in HKD
54.500
-0.650 (-1.18%)
As of 4:08PM HKT. Market open.
Stock chart is not supported by your current browser
| Previous Close | 55.150 |
| Open | 0.000 |
| Bid | 55.150 x 0 |
| Ask | 55.150 x 0 |
| Day's Range | 0.000 - 0.000 |
| 52 Week Range | |
| Volume | 0 |
| Avg. Volume | 879,053 |
| Market Cap | 32.839B |
| Beta | 0.64 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 2.46 (4.22%) |
| Ex-Dividend Date | 2018-06-22 |
| 1y Target Est | 70.45 |
- Reuters•3 months ago
BRIEF-Livzon Pharmaceutical's 2017 Net Profit Up 464.6 Percent Y/Y
March 23 (Reuters) - Livzon Pharmaceutical Group Inc : * SAYS 2017 NET PROFIT UP 464.6 PERCENT Y/Y Source text in Chinese: https://bit.ly/2IMcCqi Further company coverage: (Reporting by Hong Kong newsroom)...
- Reuters•4 months ago
BRIEF-Livzon Pharmaceutical Unit's JV Livzon Biologics' Capital Will Be Boosted By 600 Mln Yuan (Feb 7)
(Corrects currency unit in headline and bullet point to yuan, not U.S. dollar) Feb 7 (Reuters) - Livzon Pharmaceutical Group Inc : * SAYS CAPITAL AT UNIT'S JV LIVZON BIOLOGICS WILL BE BOOSTED BY 600 MILLION ...
We're sorry this is all we were able to find about this topic.